2019
DOI: 10.1002/smtd.201900506
|View full text |Cite
|
Sign up to set email alerts
|

Micro/Nano Technology for Next‐Generation Diagnostics

Abstract: There has been a constant and urgent need to upgrade the current diagnostic technologies to the next generation by utilizing innovative advanced technologies in order to meet new challenges. Micro/nano technology, a series of methods for design and manipulation materials at the micrometer and nanometer scales, which perfectly covers the key building blocks of life including cells, organelles, proteins, nucleic acids, and other components, has unique advantages over current diagnostic methods. For the applicati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 26 publications
(14 citation statements)
references
References 153 publications
0
14
0
Order By: Relevance
“…Nanoparticle-based DDSs (NP-DDSs) are widely investigated as nanocarriers for cancer treatment due to their advantages over other DDSs (e.g., microparticle-based DDSs) and free anticancer therapeutic agents. Nanocarriers have at least one size dimension in the order of 1–100 nm, a scale in which molecules of life, such as nucleic acids, proteins, and other chemicals, fall right into [ 31 , 33 , 34 ]. However, nanocarriers with dimensions smaller than 500 nm are occasionally accepted because their biochemical and physiochemical properties are easily modifiable and compatible with DDS applications [ 35 , 36 ].…”
Section: Influence Of Biological Barriers On Drug Delivery Systemsmentioning
confidence: 99%
“…Nanoparticle-based DDSs (NP-DDSs) are widely investigated as nanocarriers for cancer treatment due to their advantages over other DDSs (e.g., microparticle-based DDSs) and free anticancer therapeutic agents. Nanocarriers have at least one size dimension in the order of 1–100 nm, a scale in which molecules of life, such as nucleic acids, proteins, and other chemicals, fall right into [ 31 , 33 , 34 ]. However, nanocarriers with dimensions smaller than 500 nm are occasionally accepted because their biochemical and physiochemical properties are easily modifiable and compatible with DDS applications [ 35 , 36 ].…”
Section: Influence Of Biological Barriers On Drug Delivery Systemsmentioning
confidence: 99%
“…Antibodies and aptamers are used for the highly selective biorecognition of surface proteins from CTCs and exosomes, nucleic acids, and proteins. Aptamers are gaining popularity over antibodies because they are smaller, more stable, and more easily synthesized . They have also additional functionalities: selective cleaving of other nucleic acid strands, amplification of specific portions or catalytic activity …”
Section: Point-of-care Testing: Massive Inexpensive Fast Diagnosismentioning
confidence: 99%
“…Aptamers are gaining popularity over antibodies because they are smaller, more stable, and more easily synthesized. 30 They have also additional functionalities: selective cleaving of other nucleic acid strands, amplification of specific portions or catalytic activity. 31 Due to the small concentration of the target analytes, an amplification step is unavoidable for obtaining measurable signals.…”
mentioning
confidence: 99%
“…DNA nanotechnology-based diagnostic methods are versatile alternatives that could help address many of the challenges of biomarker detection. DNA nanostructures have been shown to be capable of detecting a variety of different biomarkers, by incorporating or conjugating with affinity reagents such as aptamers and antibodies [20][21][22][23] . Furthermore, DNA nanotechnology-based assays are compatible with a large range of readouts, including electrochemistry 24 , pH 25 , conformational changes detected via gel electrophoresis [26][27][28] , fluorescence imaging 29,30 and naked-eye colorimetric changes 31 .…”
Section: Introductionmentioning
confidence: 99%